Politico June 13, 2024
WASHINGTON WATCH
The typically flush National Cancer Institute is trying to learn how to do more with less. NCI Director Dr. W. Kimryn Rathmell spoke to the tightened budget during a NCI advisory board meeting Wednesday, in which leaders grappled with how to expand its research in the face of a tight budget.
Why it matters: Clinical trials allow scientists to offer potentially lifesaving care to patients who are out of treatment options.
The advisory board discussed how best to offer access to underserved groups, such as a lung cancer clinical trial to obtain more data from minority patients. Dr. Nilofer Azad, chair for the subcommittee on clinical investigations at NCI, and her team also want to decrease barriers to...
Today's Sponsors
Today's Sponsor